Visualization and Analysis of Parkinson's Disease Status and Therapy Patterns

Parkinson’s disease is a neurodegenerative disease affecting people worldwide. Since the reasons for Parkinson’s disease are still unknown and currently there is no cure for the disease, the management of the disease is directed towards handling of the underlying symptoms with antiparkinson medications. In this paper, we present a method for visualization of the patients’ overall status and their antiparkinson medications therapy. The purpose of the proposed visualization method is multi-fold: understanding the clinicians’ decisions for therapy modifications, identification of the underlying guidelines for management of Parkinson’s disease, as well as identifying treatment differences between groups of patients. The resulting patterns of disease progression show that there are differences between male and female patients.

[1]  P. Fayers,et al.  The Visual Display of Quantitative Information , 1990 .

[2]  A. Jette,et al.  The Physical Activity Scale for the Elderly (PASE): development and evaluation. , 1993, Journal of clinical epidemiology.

[3]  Ben Shneiderman,et al.  LifeLines: visualizing personal histories , 1996, CHI.

[4]  Luc De Raedt,et al.  Top-Down Induction of Clustering Trees , 1998, ICML.

[5]  W. Koller,et al.  An algorithm (decision tree) for the management of Parkinson’s disease (2001): , 1998, Neurology.

[6]  Silvia Miksch,et al.  Visualization methods for data analysis and planning in medical applications , 2002, Int. J. Medical Informatics.

[7]  Johan Marinus,et al.  Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.

[8]  Yorick Wilks,et al.  A Closer Look at Skip-gram Modelling , 2006, LREC.

[9]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[10]  Max A. Little,et al.  Accurate Telemonitoring of Parkinson's Disease Progression by Noninvasive Speech Tests , 2009, IEEE Transactions on Biomedical Engineering.

[11]  Max A. Little,et al.  Enhanced classical dysphonia measures and sparse regression for telemonitoring of Parkinson's disease progression , 2010, 2010 IEEE International Conference on Acoustics, Speech and Signal Processing.

[12]  T. Anderson,et al.  The MoCA , 2010, Neurology.

[13]  W. Poewe,et al.  The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[15]  Athanasios Tsanas,et al.  Accurate telemonitoring of Parkinson's disease symptom severity using nonlinear speech signal processing and statistical machine learning , 2012 .

[16]  Max A. Little,et al.  Novel Speech Signal Processing Algorithms for High-Accuracy Classification of Parkinson's Disease , 2012, IEEE Transactions on Biomedical Engineering.

[17]  A. Berardelli,et al.  Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease , 2013, European journal of neurology.

[18]  Lu Wang,et al.  Handling missing values in the MDS‐UPDRS , 2015, Movement disorders : official journal of the Movement Disorder Society.

[19]  Nada Lavrac,et al.  Multi-view Approach to Parkinson's Disease Quality of Life Data Analysis , 2016, NFMCP@PKDD/ECML.

[20]  Nada Lavrac,et al.  Analysis of medications change in Parkinson’s disease progression data , 2018, Journal of Intelligent Information Systems.

[21]  Nada Lavrac,et al.  Symptoms and medications change patterns for Parkinson's disease patients stratification , 2018, Artif. Intell. Medicine.